ADx NeuroSciences

Foundation date

16/09/2011

Sector

#Biotechnology - Therapeutics

Subsector

We create tailor-made antibodies and assays to quantify unique biomarkers in a wide variety of neurodegenerative diseases and conditions such as Alzheimer’s disease, Parkinson’s disease and traumatic brain injury. Our assays enable early detection before symptoms appear, providing valuable information from the drug development phase up to clinical practice, to improve the life of patients.

Upcoming events

Latest news

  • Indigo Diabetes announces first participant enrolled in the SHINE clinical trial

    19 hours ago

  • FINTEPLA®▼ (fenfluramine) approved in Japan for the treatment of seizures associated with Dravet syndrome

    Tuesday September 27th 2022

  • Pauwels Consulting takes over Science@Work

    Friday September 23rd 2022